Disease_category,Disease,Protein,Protein_definition,Method,Nb_SNP,OR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ROBO1,Roundabout homolog 1,Inverse variance weighted,25,1.08 [0.93-1.25],0.307914951356556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,29,1.03 [0.96-1.10],0.423370470320761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,24,1.01 [0.85-1.21],0.877494382814617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BOC,Brother of CDO,Inverse variance weighted,15,0.96 [0.81-1.13],0.623619562620242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,5,1.40 [0.63-3.10],0.407500214486428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,27,0.97 [0.90-1.04],0.388855963592017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.90 [0.69-1.17],0.430315883536359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,2,1.10 [0.67-1.81],0.696080110015897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,9,1.28 [0.83-1.97],0.2669767147583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,12,0.94 [0.75-1.17],0.578185501777285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG1B,Lithostathine-1-beta,Inverse variance weighted,26,1.04 [0.93-1.15],0.494046808214929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,1.00 [0.88-1.13],0.943364567445672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,Inverse variance weighted,35,1.01 [0.85-1.21],0.885452803989625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD48,CD48 antigen,Inverse variance weighted,32,0.98 [0.90-1.05],0.528633770728939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,6,1.22 [0.93-1.60],0.144498143340552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL12A_IL12B,Interleukin-12,Inverse variance weighted,57,1.01 [0.92-1.10],0.894039826124062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,28,0.90 [0.81-1.01],0.0762748741069497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,29,0.96 [0.82-1.14],0.665519888812925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,Inverse variance weighted,2,1.50 [0.84-2.68],0.167610685909282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PENK,Proenkephalin-A,Inverse variance weighted,21,1.06 [0.89-1.26],0.544352089745837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH17,Cadherin-17,Inverse variance weighted,44,1.01 [0.93-1.10],0.736611964592131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCGB1A1,Uteroglobin,Inverse variance weighted,49,1.01 [0.92-1.12],0.818790101539468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,16,0.87 [0.72-1.05],0.148418210142455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,17,0.99 [0.86-1.13],0.841922808838785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,17,1.14 [1.00-1.30],0.0543051925980764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADA2,Adenosine deaminase 2,Inverse variance weighted,18,1.15 [0.97-1.37],0.105920306406437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PKD1,Polycystin-1,Inverse variance weighted,23,1.06 [0.91-1.23],0.468462668905899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,22,1.24 [1.06-1.43],0.0054518733468162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMSB10,Thymosin beta-10,Wald ratio,1,1.49 [0.66-3.37],0.33955916795248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.14 [0.82-1.58],0.435521130270631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,4,0.92 [0.69-1.23],0.576562398288401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HEPH,Hephaestin,Inverse variance weighted,6,1.34 [1.05-1.72],0.0201685935577551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,49,1.02 [0.95-1.10],0.572305700301249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.89 [0.59-1.36],0.596890252233164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBP2,Retinol-binding protein 2,Inverse variance weighted,6,1.13 [0.66-1.94],0.656896743758143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSAP,Prosaposin,Inverse variance weighted,13,0.85 [0.73-0.99],0.0399652680312638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,40,0.99 [0.89-1.10],0.781480653191318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA14,Carbonic anhydrase 14,Inverse variance weighted,21,1.08 [0.85-1.36],0.534841224925076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,4,1.03 [0.68-1.55],0.884098055117109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,12,0.92 [0.69-1.24],0.596392842044276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRELP,Prolargin,Inverse variance weighted,14,0.79 [0.69-0.91],0.0009915579978754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGL1,Fibrinogen-like protein 1,Inverse variance weighted,38,1.04 [0.93-1.15],0.526034248834073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,20,1.01 [0.87-1.17],0.898139547573524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GUCA2A,Guanylin,Inverse variance weighted,16,0.99 [0.82-1.19],0.910144001470139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD200,OX-2 membrane glycoprotein,Inverse variance weighted,15,1.02 [0.88-1.18],0.823855669500538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,14,1.03 [0.90-1.19],0.645666182727171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOA4,Apolipoprotein A-IV,Inverse variance weighted,5,0.87 [0.52-1.48],0.613129784207348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,8,1.01 [0.79-1.29],0.919274052207998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.96 [0.70-1.30],0.780213729599858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD109,CD109 antigen,Inverse variance weighted,71,0.99 [0.93-1.05],0.73515024792849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA3,Carbonic anhydrase 3,Inverse variance weighted,16,1.01 [0.83-1.23],0.890436534798107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DSG2,Desmoglein-2,Inverse variance weighted,22,1.04 [0.90-1.20],0.60573085019023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,4,1.18 [0.66-2.09],0.576307931662021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DPY30,Protein dpy-30 homolog,Inverse variance weighted,2,0.98 [0.29-3.35],0.972979899232766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,1.15 [0.77-1.71],0.501311411665478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADM,Pro-adrenomedullin,Inverse variance weighted,4,0.87 [0.69-1.10],0.242808128383758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1.06 [0.96-1.17],0.287815692308696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PGF,Placenta growth factor,Inverse variance weighted,8,0.82 [0.42-1.59],0.556763916872726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,25,1.01 [0.83-1.22],0.95235272115968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLSTN2,Calsyntenin-2,Inverse variance weighted,38,0.99 [0.91-1.08],0.843962610960871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FBLN2,Fibulin-2,Inverse variance weighted,17,0.97 [0.85-1.11],0.683528485967447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,5,0.93 [0.72-1.20],0.571909218572408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,66,1.00 [0.95-1.06],0.885768564572334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,18,0.97 [0.70-1.35],0.873512011423906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSO,Cathepsin O,Inverse variance weighted,22,1.01 [0.88-1.15],0.920357759369781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THBS2,Thrombospondin-2,Inverse variance weighted,33,1.02 [0.94-1.12],0.629725190397949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBP7,Retinoid-binding protein 7,Inverse variance weighted,15,1.04 [0.90-1.19],0.626727291763566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MB,Myoglobin,Inverse variance weighted,10,0.75 [0.51-1.09],0.129336593440291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.96 [0.75-1.23],0.72114291525412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,43,0.98 [0.92-1.05],0.641425946770685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,42,0.98 [0.91-1.06],0.582751221210794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,76,1.05 [1.00-1.09],0.0432190445189853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LPO,Lactoperoxidase,Inverse variance weighted,34,1.06 [0.96-1.18],0.272873562407698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PI3,Elafin,Inverse variance weighted,20,1.14 [1.00-1.31],0.0480014014061239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRTG,Protogenin,Inverse variance weighted,34,1.05 [0.97-1.13],0.212378139945686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FSTL3,Follistatin-related protein 3,Inverse variance weighted,7,0.99 [0.67-1.45],0.939772552064514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRSS27,Serine protease 27,Inverse variance weighted,51,1.02 [0.93-1.11],0.707359382397616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,22,1.06 [0.85-1.32],0.594116014680582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,21,0.88 [0.71-1.08],0.206076024102882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRYBB2,Beta-crystallin B2,Inverse variance weighted,31,0.93 [0.81-1.08],0.372324254771204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DKK3,Dickkopf-related protein 3,Inverse variance weighted,28,0.97 [0.87-1.08],0.578888915979066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,36,1.05 [0.95-1.16],0.363845045419721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,18,1.01 [0.85-1.19],0.938909609888602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NFASC,Neurofascin,Inverse variance weighted,19,1.06 [0.95-1.19],0.32217085085462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,3,1.00 [0.53-1.90],0.99603705682306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,11,0.95 [0.81-1.10],0.475230007558081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,11,0.93 [0.67-1.31],0.691466241106228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,Inverse variance weighted,45,0.98 [0.94-1.03],0.42904786576184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,11,1.06 [0.97-1.15],0.192363577147549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,30,0.90 [0.75-1.07],0.243004516485225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CKB,Creatine kinase B-type,Inverse variance weighted,11,1.09 [0.65-1.83],0.752267862470629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,22,1.02 [0.91-1.14],0.761896768038462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,11,0.99 [0.71-1.37],0.943726033321969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PALM2,Paralemmin-2,Inverse variance weighted,9,1.26 [1.04-1.52],0.0171620534376446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,0.99 [0.84-1.18],0.931831847179164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IDI2,Isopentenyl-diphosphate delta-isomerase 2,Inverse variance weighted,12,0.94 [0.84-1.06],0.293571043853847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C7,Complement component C7,Inverse variance weighted,60,1.04 [0.99-1.09],0.15314171878482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSPB6,Heat shock protein beta-6,Inverse variance weighted,5,0.83 [0.54-1.28],0.399679197378589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,11,0.87 [0.75-1.00],0.0535964244364141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,15,1.00 [0.85-1.18],0.981233209893958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,30,1.02 [0.88-1.19],0.781559888926796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAM3C,Protein FAM3C,Inverse variance weighted,5,1.15 [0.73-1.80],0.545581635811865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD276,CD276 antigen,Inverse variance weighted,47,1.05 [0.98-1.13],0.179313978238687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRSS8,Prostasin,Inverse variance weighted,19,1.23 [1.02-1.48],0.0287981958404849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,54,1.04 [0.95-1.13],0.443423344226855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UMOD,Uromodulin,Inverse variance weighted,62,0.97 [0.91-1.04],0.39901181725143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,16,1.04 [0.93-1.16],0.520989951689856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA4,Carbonic anhydrase 4,Inverse variance weighted,25,0.91 [0.81-1.03],0.146306570988406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,22,1.02 [0.98-1.07],0.367526890889081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,5,1.04 [0.71-1.52],0.828616835753802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CALB1,Calbindin,Inverse variance weighted,11,0.87 [0.67-1.12],0.266445247839704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",Wald ratio,1,0.69 [0.28-1.66],0.403333016385123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHGB,Secretogranin-1,Inverse variance weighted,33,1.05 [0.96-1.14],0.300024232976032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,17,1.02 [0.81-1.28],0.870110190712157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OCLN,Occludin,Inverse variance weighted,3,0.85 [0.60-1.20],0.355867472473104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPR37,Prosaposin receptor GPR37,Inverse variance weighted,62,0.99 [0.92-1.06],0.73692600455926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,36,1.04 [0.96-1.12],0.362200124347354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,27,0.96 [0.82-1.12],0.581051056938668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,26,1.06 [0.90-1.24],0.477907796443575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD59,CD59 glycoprotein,Inverse variance weighted,8,1.02 [0.81-1.30],0.842915612036424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.11 [0.82-1.52],0.491466183121205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PALM,Paralemmin-1,Inverse variance weighted,10,1.04 [0.82-1.33],0.752788646208136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA12,Carbonic anhydrase 12,Inverse variance weighted,20,1.05 [0.93-1.18],0.433906058874513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,8,1.01 [0.76-1.36],0.936717334441766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VIT,Vitrin,Inverse variance weighted,38,0.97 [0.90-1.03],0.320560700578782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCDH17,Protocadherin-17,Inverse variance weighted,47,1.05 [0.98-1.13],0.190910104377222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",Inverse variance weighted,7,0.93 [0.79-1.09],0.362187522627011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,41,1.00 [0.88-1.12],0.962822676665655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,39,0.91 [0.81-1.02],0.113515478119046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",INHBB,Inhibin beta B chain,Inverse variance weighted,16,0.86 [0.65-1.13],0.267727917230852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,11,1.19 [0.99-1.42],0.0626927610347464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,30,0.90 [0.78-1.04],0.142167240398345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS9,Galectin-9,Inverse variance weighted,39,0.96 [0.86-1.08],0.533372646967737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH15,Cadherin-15,Inverse variance weighted,22,0.95 [0.85-1.06],0.357494330757673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH6,Cadherin-6,Inverse variance weighted,34,1.01 [0.94-1.09],0.783087002944341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STC1,Stanniocalcin-1,Inverse variance weighted,11,1.10 [0.82-1.48],0.506506677301677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,20,0.92 [0.80-1.06],0.271862690050469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THBS4,Thrombospondin-4,Inverse variance weighted,20,1.05 [0.91-1.20],0.520044079802401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.88 [0.60-1.28],0.503599739089248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE1,Ribonuclease pancreatic,Inverse variance weighted,6,1.02 [0.71-1.47],0.916832333097266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,42,0.91 [0.82-1.00],0.0622756669434937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD93,Complement component C1q receptor,Inverse variance weighted,2,0.96 [0.27-3.42],0.944133127069563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL16,Pro-interleukin-16,Inverse variance weighted,20,0.90 [0.80-1.00],0.0538357314340999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RETN,Resistin,Inverse variance weighted,28,1.02 [0.93-1.12],0.688040500297088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DSC2,Desmocollin-2,Inverse variance weighted,16,0.99 [0.84-1.18],0.9542490770881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VASN,Vasorin,Inverse variance weighted,19,1.06 [0.97-1.15],0.189270167842808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,24,1.07 [0.93-1.23],0.325928973952402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EDN1,Endothelin-1,Inverse variance weighted,3,1.05 [0.82-1.33],0.711648501662231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MILR1,Allergin-1,Inverse variance weighted,43,0.96 [0.91-1.01],0.149779199775767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AFM,Afamin,Inverse variance weighted,12,0.92 [0.68-1.24],0.573877516438142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,32,0.99 [0.93-1.05],0.663590894859634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,0.93 [0.77-1.11],0.412647981200519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCN5,CCN family member 5,Inverse variance weighted,12,1.00 [0.83-1.20],0.984340742849664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD7,T-cell antigen CD7,Inverse variance weighted,12,0.95 [0.84-1.07],0.365540350311917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COLEC12,Collectin-12,Inverse variance weighted,13,0.99 [0.81-1.21],0.917021785968081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE4,Ribonuclease 4,Inverse variance weighted,13,0.98 [0.86-1.13],0.805733245155743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DLL1,Delta-like protein 1,Inverse variance weighted,13,1.00 [0.75-1.33],0.98378812036293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPY,Pro-neuropeptide Y,Inverse variance weighted,18,0.99 [0.78-1.24],0.902514807334585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RGMA,Repulsive guidance molecule A,Inverse variance weighted,47,1.04 [0.94-1.16],0.426962304671492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AOC3,Membrane primary amine oxidase,Inverse variance weighted,36,0.97 [0.88-1.08],0.594269544280355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.98 [0.53-1.81],0.935871836576049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEPTIN8,Septin-8,Inverse variance weighted,6,0.94 [0.68-1.30],0.694478244165246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NUCB2,Nucleobindin-2,Inverse variance weighted,28,0.92 [0.82-1.03],0.153165576006395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,22,0.92 [0.80-1.07],0.289710081310451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.09 [0.99-1.21],0.0845908130066215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL18BP,Interleukin-18-binding protein,Inverse variance weighted,13,1.07 [0.86-1.34],0.547884725544992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA9,Carbonic anhydrase 9,Inverse variance weighted,11,0.97 [0.77-1.22],0.78818027949696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TREML2,Trem-like transcript 2 protein,Inverse variance weighted,19,1.15 [1.00-1.31],0.0452425070143555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,25,0.95 [0.88-1.03],0.210543850375314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPO,Erythropoietin,Inverse variance weighted,14,1.10 [0.91-1.32],0.3104152758731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMPRSS15,Enteropeptidase,Inverse variance weighted,11,1.02 [0.74-1.41],0.905868805930355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLAMF8,SLAM family member 8,Inverse variance weighted,28,1.00 [0.95-1.05],0.955374897464234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,61,1.09 [1.03-1.16],0.0029563683049902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSZ,Cathepsin Z,Inverse variance weighted,16,0.94 [0.85-1.05],0.285807544143361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,66,1.02 [0.95-1.09],0.668572485628046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LY6D,Lymphocyte antigen 6D,Inverse variance weighted,31,0.99 [0.90-1.08],0.770173877586155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,34,1.07 [0.94-1.21],0.293634986162604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,28,1.06 [0.96-1.17],0.284988918294877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,17,1.06 [0.94-1.20],0.354133413722119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD207,C-type lectin domain family 4 member K,Inverse variance weighted,38,1.01 [0.91-1.12],0.885365883759102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AFP,Alpha-fetoprotein,Inverse variance weighted,70,0.93 [0.84-1.04],0.195834555691823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.12 [0.84-1.51],0.439514736178038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.04 [0.96-1.11],0.344202036843656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,9,1.26 [0.81-1.97],0.301107895625437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNCG,Gamma-synuclein,Inverse variance weighted,49,1.01 [0.93-1.10],0.76074200702869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.92 [0.79-1.08],0.310073321718052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,44,1.01 [0.95-1.08],0.79114708300826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,11,0.98 [0.75-1.29],0.898432194359457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,10,0.96 [0.78-1.20],0.736494148860666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,24,1.05 [0.94-1.18],0.393461086931481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.89 [0.74-1.08],0.235945536584528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,0.90 [0.57-1.43],0.656143651289119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH3,Cadherin-3,Inverse variance weighted,12,0.91 [0.66-1.24],0.540098272160242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,10,0.94 [0.80-1.11],0.486801769745264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAM3D,Protein FAM3D,Inverse variance weighted,56,0.96 [0.89-1.04],0.308952911766679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PREB,Prolactin regulatory element-binding protein,Wald ratio,1,1.18 [0.37-3.75],0.784481085325373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,9,1.07 [0.94-1.21],0.30502574682271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGB2,Integrin beta-2,Inverse variance weighted,20,1.05 [0.82-1.36],0.687978152793644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF23,Fibroblast growth factor 23,Inverse variance weighted,17,0.93 [0.77-1.13],0.491323768190512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",S100P,Protein S100-P,Inverse variance weighted,8,1.05 [0.85-1.28],0.667556621694511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,19,0.95 [0.82-1.08],0.423647256508911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,17,0.91 [0.69-1.18],0.47259996620089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL21,C-C motif chemokine 21,Inverse variance weighted,19,1.04 [0.81-1.34],0.766307581150301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDCD1,Programmed cell death protein 1,Inverse variance weighted,24,0.96 [0.74-1.24],0.769027334163133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNTN2,Contactin-2,Inverse variance weighted,40,1.01 [0.95-1.07],0.780478940265134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,40,0.94 [0.84-1.05],0.289588406927166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASET2,Ribonuclease T2,Inverse variance weighted,25,1.01 [0.91-1.12],0.845336053748048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,2,0.82 [0.27-2.52],0.728041118173248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,13,0.98 [0.85-1.14],0.810746043554785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MCAM,Cell surface glycoprotein MUC18,Inverse variance weighted,13,1.12 [0.95-1.33],0.187021863612731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFF1,Trefoil factor 1,Inverse variance weighted,14,0.99 [0.86-1.14],0.87643848173981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,10,1.13 [0.84-1.51],0.424865520813796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD302,CD302 antigen,Inverse variance weighted,17,0.92 [0.81-1.05],0.220905918895868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL11,Eotaxin,Inverse variance weighted,11,1.03 [0.87-1.22],0.709994424066502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,8,1.07 [0.82-1.40],0.603347635034812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP7,Matrilysin,Inverse variance weighted,15,1.07 [0.93-1.23],0.347932549464701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,Inverse variance weighted,51,1.04 [0.94-1.14],0.471324857427662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,10,1.02 [0.76-1.37],0.888122393121866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCARB2,Lysosome membrane protein 2,Inverse variance weighted,17,1.06 [0.88-1.26],0.562666856469584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,30,0.99 [0.89-1.11],0.923994239423976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EBI3_IL27,Interleukin-27,Inverse variance weighted,37,1.06 [0.95-1.17],0.294823168030523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,26,0.95 [0.83-1.09],0.478262429309858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,42,0.90 [0.80-1.02],0.102561803943218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,8,0.77 [0.59-1.00],0.048865265299454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.02 [0.89-1.18],0.757797582037942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,35,1.00 [0.90-1.11],0.996794880262506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC3B,Tetranectin,Inverse variance weighted,9,0.91 [0.75-1.10],0.320154050749102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSE,Cathepsin E,Inverse variance weighted,21,1.03 [0.92-1.15],0.633272722756695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,Inverse variance weighted,37,0.96 [0.86-1.08],0.513002277041235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.04 [0.97-1.11],0.284778017260983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,25,1.07 [0.95-1.19],0.259325982425055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GAS6,Growth arrest-specific protein 6,Inverse variance weighted,28,1.10 [0.96-1.27],0.164038434325808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFF3,Trefoil factor 3,Inverse variance weighted,10,1.03 [0.72-1.49],0.866370249090416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNTN1,Contactin-1,Inverse variance weighted,45,0.98 [0.86-1.11],0.696902220525443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,27,1.00 [0.95-1.06],0.996815113826172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,26,1.01 [0.90-1.13],0.899987345871001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,15,0.91 [0.79-1.05],0.202484867843996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,26,0.96 [0.86-1.07],0.468085447657521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1.03 [0.76-1.38],0.866782489128629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCG2,Secretogranin-2,Inverse variance weighted,3,1.21 [0.72-2.01],0.475763326541184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,37,0.97 [0.90-1.05],0.490101504835194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS4,Galectin-4,Inverse variance weighted,19,0.92 [0.80-1.06],0.259326260691224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,18,0.98 [0.83-1.15],0.779603122758059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AREG,Amphiregulin,Inverse variance weighted,7,1.05 [0.75-1.48],0.774929733303787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,0.98 [0.69-1.40],0.928048850644612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.06 [0.53-2.12],0.875603108328207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFF2,Trefoil factor 2,Inverse variance weighted,16,0.86 [0.70-1.04],0.116196949032384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,75,0.99 [0.93-1.06],0.807445467193906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MUC13,Mucin-13,Inverse variance weighted,13,0.93 [0.78-1.11],0.431755687325694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPC1,Glypican-1,Inverse variance weighted,43,0.99 [0.90-1.08],0.800117670344346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,26,0.97 [0.86-1.09],0.589289974067155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,29,0.97 [0.87-1.07],0.518489094101494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAM3B,Protein FAM3B,Inverse variance weighted,26,1.04 [0.96-1.12],0.331006774215651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,38,0.97 [0.91-1.04],0.423585196809593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLXNB2,Plexin-B2,Inverse variance weighted,37,1.01 [0.96-1.07],0.722539508920787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FOLR1,Folate receptor alpha,Inverse variance weighted,10,0.88 [0.68-1.15],0.355973491990944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK11,Kallikrein-11,Inverse variance weighted,19,1.15 [1.05-1.26],0.0033436061218208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC1,Sialoadhesin,Inverse variance weighted,31,1.09 [0.96-1.23],0.193441038891394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,35,0.93 [0.85-1.02],0.13127713305611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REN,Renin,Inverse variance weighted,12,1.01 [0.80-1.27],0.933905885370609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL17C,Interleukin-17C,Inverse variance weighted,8,0.86 [0.65-1.14],0.2892620378766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL12B,Interleukin-12 subunit beta,Inverse variance weighted,63,1.03 [0.93-1.13],0.610783863489962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCG3,Secretogranin-3,Inverse variance weighted,48,0.94 [0.85-1.03],0.174052588925389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,21,1.01 [0.83-1.23],0.907778552352342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,14,1.06 [0.79-1.43],0.680375531313255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,23,1.04 [0.85-1.27],0.687036860369244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,33,0.96 [0.85-1.09],0.532298270144139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RGMB,RGM domain family member B,Inverse variance weighted,10,1.18 [0.96-1.44],0.114688903179371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,0.87 [0.48-1.58],0.650141803854308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SHISA5,Protein shisa-5,Inverse variance weighted,16,1.60 [1.21-2.13],0.0010837751318572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD46,Membrane cofactor protein,Inverse variance weighted,3,0.91 [0.54-1.53],0.728025655271147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,1.94 [0.37-10.04],0.429743485808498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,12,1.09 [0.88-1.35],0.436916833868172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",F2R,Proteinase-activated receptor 1,Inverse variance weighted,8,1.12 [0.82-1.53],0.471826708463093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SOST,Sclerostin,Inverse variance weighted,31,0.97 [0.85-1.11],0.696883450216022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,50,0.96 [0.88-1.04],0.317939434966411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HYAL1,Hyaluronidase-1,Inverse variance weighted,23,1.01 [0.90-1.12],0.90966345467226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANXA5,Annexin A5,Inverse variance weighted,2,1.05 [0.67-1.65],0.825958545487552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ELN,Elastin,Inverse variance weighted,12,0.96 [0.70-1.31],0.807540972065687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,9,1.17 [0.90-1.51],0.239463924908196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GM2A,Ganglioside GM2 activator,Inverse variance weighted,26,0.99 [0.92-1.07],0.850965260691954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RSPO3,R-spondin-3,Inverse variance weighted,11,0.91 [0.74-1.12],0.377457841584522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,18,0.94 [0.83-1.07],0.370835921860366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,20,1.09 [1.02-1.18],0.015152994964575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,40,1.04 [0.96-1.13],0.341248934850129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PYY,Peptide YY,Inverse variance weighted,16,1.00 [0.86-1.16],0.952804326073841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WNT9A,Protein Wnt-9a,Inverse variance weighted,7,1.09 [0.83-1.43],0.528474526229476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,3,2.01 [0.90-4.48],0.0872579138588636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS3,Galectin-3,Inverse variance weighted,42,1.02 [0.94-1.12],0.614284335398591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYBPC2,"Myosin-binding protein C, fast-type",Inverse variance weighted,5,1.01 [0.51-2.01],0.967332791062639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPON1,Spondin-1,Inverse variance weighted,25,0.95 [0.85-1.06],0.353801168765143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,Inverse variance weighted,11,1.10 [0.83-1.45],0.518493118167848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",POF1B,Protein POF1B,Inverse variance weighted,4,0.72 [0.47-1.09],0.121171583564801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,28,1.02 [0.94-1.12],0.612946520920581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL19,Interleukin-19,Inverse variance weighted,21,1.05 [0.94-1.17],0.427908078615109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,0.96 [0.87-1.06],0.407715975395653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FSTL1,Follistatin-related protein 1,Inverse variance weighted,15,1.12 [0.90-1.39],0.313222152843457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,Inverse variance weighted,12,1.16 [0.91-1.49],0.236089239091466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CX3CL1,Fractalkine,Inverse variance weighted,23,1.04 [0.86-1.25],0.687757078126436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,7,1.04 [0.76-1.43],0.812161266683163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,19,1.05 [0.91-1.22],0.505410439977224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THBD,Thrombomodulin,Inverse variance weighted,16,1.07 [0.93-1.23],0.342723077527772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,1.12 [0.53-2.34],0.766289006488629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,25,0.94 [0.83-1.06],0.302230683199201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPON2,Spondin-2,Inverse variance weighted,8,1.00 [0.84-1.20],0.959841325656284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,19,0.98 [0.88-1.10],0.724818738390572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DCN,Decorin,Inverse variance weighted,3,0.66 [0.34-1.31],0.238935480132938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.13 [0.37-3.46],0.835794590587682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DLK1,Protein delta homolog 1,Inverse variance weighted,33,1.03 [0.92-1.14],0.62683636437619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,10,0.94 [0.66-1.34],0.718738136534176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,12,1.07 [0.88-1.29],0.498895153526476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTRC,Chymotrypsin-C,Inverse variance weighted,43,1.02 [0.95-1.10],0.547898313692446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CALB2,Calretinin,Wald ratio,1,1.19 [0.55-2.57],0.665760521423847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BSG,Basigin,Inverse variance weighted,8,1.03 [0.80-1.34],0.795793449806311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL14,C-C motif chemokine 14,Inverse variance weighted,17,0.90 [0.81-0.99],0.0338147481472938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.90 [0.70-1.15],0.399479866456515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GRN,Progranulin,Inverse variance weighted,46,0.98 [0.90-1.06],0.612381921905521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,17,0.71 [0.57-0.88],0.0015465527829627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,23,0.92 [0.78-1.10],0.37537046580067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,19,1.00 [0.90-1.13],0.936109044984058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD99,CD99 antigen,Inverse variance weighted,4,0.93 [0.63-1.37],0.703016685210375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,13,1.08 [0.96-1.23],0.20500519061465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AMBP,Protein AMBP,Inverse variance weighted,5,1.02 [0.64-1.61],0.935453000932956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,15,0.97 [0.83-1.14],0.741486499025691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,6,0.99 [0.77-1.27],0.931532176256212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,11,0.92 [0.77-1.11],0.404682810144253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,17,1.27 [1.06-1.52],0.0098634232771418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LCN15,Lipocalin-15,Inverse variance weighted,22,0.89 [0.80-1.00],0.0504529083412699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,31,1.10 [0.97-1.26],0.132590241301508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPA2,Carboxypeptidase A2,Inverse variance weighted,27,1.00 [0.90-1.12],0.944438506087894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,23,1.03 [0.94-1.12],0.50765435435816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPT2,Angiopoietin-2,Inverse variance weighted,11,0.91 [0.75-1.10],0.322502513019044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GDF15,Growth/differentiation factor 15,Inverse variance weighted,14,1.25 [0.97-1.61],0.0816017274463336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLIN3,Perilipin-3,Wald ratio,1,1.11 [0.58-2.14],0.753719797139238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAMA4,Laminin subunit alpha-4,Inverse variance weighted,17,0.92 [0.80-1.06],0.260496636343047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.99 [0.80-1.23],0.961102758657843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOC1,Apolipoprotein C-I,Inverse variance weighted,18,0.84 [0.66-1.06],0.139167287725348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,30,1.00 [0.90-1.10],0.941968941833674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,1.53 [0.63-3.73],0.346868968121033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,23,0.96 [0.85-1.08],0.50201892628203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300E,CMRF35-like molecule 2,Inverse variance weighted,36,0.98 [0.87-1.11],0.739668888820161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,22,0.83 [0.72-0.97],0.0187838079072153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,16,0.99 [0.82-1.19],0.910168063274777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.44 [0.19-1.01],0.0521059614866759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSL,Cathepsin L1,Inverse variance weighted,29,0.96 [0.79-1.15],0.632306214473203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK4,Kallikrein-4,Inverse variance weighted,20,1.08 [0.96-1.22],0.17814067629856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,13,1.25 [0.89-1.75],0.199258755759777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG4,Regenerating islet-derived protein 4,Inverse variance weighted,19,0.84 [0.71-1.01],0.0654582068588943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LEP,Leptin,Inverse variance weighted,4,1.55 [0.31-7.67],0.593843418511689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CST3,Cystatin-C,Inverse variance weighted,13,1.14 [0.97-1.33],0.114154575074874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,20,1.05 [0.92-1.20],0.466979999798289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,5,1.24 [0.73-2.10],0.430059696110126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,1.27 [0.88-1.85],0.201111878426752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS1,Galectin-1,Inverse variance weighted,7,1.08 [0.90-1.28],0.423996429207174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LMNB2,Lamin-B2,Inverse variance weighted,9,0.80 [0.50-1.28],0.352879336774477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,1.34 [0.17-10.51],0.780722302680893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,10,0.85 [0.62-1.15],0.283313271303266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,31,1.05 [0.96-1.15],0.320276414334677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,31,0.99 [0.93-1.05],0.648558651105644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,8,1.06 [0.78-1.42],0.720315886375387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",XG,Glycoprotein Xg,Inverse variance weighted,2,0.44 [0.20-0.97],0.0411509125629547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFNA4,Ephrin-A4,Inverse variance weighted,5,1.00 [0.65-1.56],0.983593558426214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.00 [0.92-1.09],0.988974816682856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRG2,Bone marrow proteoglycan,Inverse variance weighted,40,0.90 [0.78-1.03],0.111969584052572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300LG,CMRF35-like molecule 9,Inverse variance weighted,24,1.08 [0.92-1.28],0.343412963245239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VWC2,Brorin,Inverse variance weighted,35,0.98 [0.87-1.10],0.688200178639656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK8,Kallikrein-8,Inverse variance weighted,17,1.14 [1.01-1.30],0.0388411878963514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,Inverse variance weighted,41,1.00 [0.93-1.08],0.99522771264311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,16,1.00 [0.90-1.11],0.995278367081018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,34,0.97 [0.90-1.06],0.520122288654205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEMA3F,Semaphorin-3F,Inverse variance weighted,46,1.25 [1.09-1.44],0.0014941400672763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,9,0.85 [0.62-1.16],0.29566789611853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE6,Ribonuclease K6,Inverse variance weighted,20,1.12 [1.01-1.25],0.0285880243305233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300LF,CMRF35-like molecule 1,Inverse variance weighted,35,1.05 [0.99-1.12],0.112500403316973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRND,Prion-like protein doppel,Inverse variance weighted,24,0.98 [0.86-1.12],0.792829876782013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLMP,CXADR-like membrane protein,Inverse variance weighted,15,0.94 [0.83-1.07],0.357598229122834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEMA7A,Semaphorin-7A,Inverse variance weighted,25,1.05 [0.86-1.28],0.664404242740346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,13,1.01 [0.60-1.72],0.956643975653898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCN4,CCN family member 4,Inverse variance weighted,40,0.99 [0.90-1.09],0.837490706815041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HNMT,Histamine N-methyltransferase,Inverse variance weighted,32,0.99 [0.91-1.09],0.890374774914094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NRP1,Neuropilin-1,Inverse variance weighted,26,0.92 [0.82-1.03],0.138843018415604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHGA,Chromogranin-A,Inverse variance weighted,8,0.96 [0.79-1.17],0.675363855383835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,31,1.38 [1.14-1.68],0.0009846553813891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNTN4,Contactin-4,Inverse variance weighted,35,0.94 [0.85-1.04],0.213333818822077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,22,1.07 [0.90-1.27],0.435078237873478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,13,1.27 [0.99-1.62],0.0616578033894345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,15,1.04 [0.91-1.19],0.558391993111431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPP1,Osteopontin,Inverse variance weighted,19,1.15 [0.93-1.43],0.19929824126024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.25 [0.84-1.88],0.276363835928725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFA,Protransforming growth factor alpha,Inverse variance weighted,11,0.94 [0.73-1.21],0.625519314743967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH1,Cadherin-1,Inverse variance weighted,17,0.90 [0.78-1.04],0.149061001336684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,19,1.09 [0.92-1.29],0.320623826637371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MFGE8,Lactadherin,Inverse variance weighted,26,1.01 [0.87-1.16],0.927070050730364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,3,1.08 [0.67-1.75],0.754862157579007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AGRN,Agrin,Inverse variance weighted,31,0.93 [0.81-1.08],0.344655904936676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",XCL1,Lymphotactin,Inverse variance weighted,47,0.99 [0.92-1.07],0.860631755090147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AHNAK2,Protein AHNAK2,Inverse variance weighted,7,1.21 [0.99-1.47],0.0568259199443246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PI16,Peptidase inhibitor 16,Inverse variance weighted,36,0.97 [0.85-1.10],0.633757773140274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,75,0.99 [0.95-1.04],0.711256539639805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TCN2,Transcobalamin-2,Inverse variance weighted,66,0.98 [0.92-1.04],0.491559348385472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,6,1.36 [0.83-2.22],0.223358149186927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HMCN2,Hemicentin-2,Inverse variance weighted,43,0.96 [0.91-1.02],0.204812119916845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DTNB,Dystrobrevin beta,Inverse variance weighted,4,0.71 [0.39-1.27],0.245410966709219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,14,1.25 [0.94-1.66],0.132022972283401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,36,1.18 [1.04-1.33],0.0083319188811667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD83,CD83 antigen,Inverse variance weighted,19,0.93 [0.77-1.13],0.49477231822107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,0.43 [0.14-1.37],0.154963345707968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,22,1.09 [1.01-1.19],0.037858887709466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,15,0.97 [0.78-1.21],0.808922313640941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCN3,CCN family member 3,Inverse variance weighted,20,1.00 [0.87-1.14],0.963678773492151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,10,1.10 [0.77-1.58],0.591013201129252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,Inverse variance weighted,14,0.97 [0.80-1.17],0.731603603243398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,31,0.95 [0.82-1.10],0.461617270592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",F3,Tissue factor,Inverse variance weighted,26,1.04 [0.85-1.27],0.682990243132965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,0.78 [0.62-0.98],0.0300881703736953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.02 [0.67-1.54],0.936008811439299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,15,0.96 [0.83-1.13],0.646567335139413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEZ6L,Seizure 6-like protein,Inverse variance weighted,18,0.91 [0.74-1.10],0.326290265505196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,15,1.18 [0.93-1.48],0.170175657005523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RTN4R,Reticulon-4 receptor,Inverse variance weighted,26,1.00 [0.90-1.13],0.942757608336787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BRK1,Protein BRICK1,Inverse variance weighted,10,0.86 [0.64-1.15],0.305234284679372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSS,Cathepsin S,Inverse variance weighted,30,0.93 [0.84-1.02],0.101722167378315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DKK4,Dickkopf-related protein 4,Inverse variance weighted,18,1.18 [0.93-1.49],0.178629410033333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,6,1.11 [0.92-1.34],0.283004111786321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,1.26 [0.86-1.84],0.240435383789849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",Inverse variance weighted,17,1.07 [0.94-1.23],0.31038989484916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,18,0.99 [0.86-1.13],0.827196804794856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP10,Stromelysin-2,Inverse variance weighted,30,1.05 [0.94-1.18],0.346198492238513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,23,0.99 [0.87-1.13],0.909730857131305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,0.97 [0.79-1.20],0.796594484657435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCDH7,Protocadherin-7,Inverse variance weighted,6,0.84 [0.54-1.32],0.445818347837025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,7,0.93 [0.73-1.17],0.518209844053295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,5,0.78 [0.48-1.25],0.30144481116196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,10,0.98 [0.81-1.19],0.840270921495159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG1A,Lithostathine-1-alpha,Inverse variance weighted,26,1.02 [0.92-1.14],0.669787578335834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD164,Sialomucin core protein 24,Inverse variance weighted,11,1.19 [0.89-1.59],0.230608469130465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.96 [0.87-1.05],0.350627712352674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,29,1.00 [0.90-1.10],0.978773184260949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,14,1.05 [0.90-1.23],0.496546910168633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,4,1.14 [0.75-1.72],0.531640721802636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRIP2,Cysteine-rich protein 2,Inverse variance weighted,11,0.80 [0.63-1.03],0.0887904384193208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NECTIN2,Nectin-2,Inverse variance weighted,8,0.98 [0.81-1.19],0.848403508974523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAYN,Layilin,Inverse variance weighted,23,1.00 [0.88-1.14],0.957999930175108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,0.99 [0.81-1.20],0.887937787150942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,Inverse variance weighted,11,0.96 [0.74-1.25],0.751181433091801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPM,Carboxypeptidase M,Inverse variance weighted,23,0.99 [0.78-1.27],0.952092339685323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DPT,Dermatopontin,Inverse variance weighted,26,1.08 [0.95-1.23],0.229618069516796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,29,1.00 [0.87-1.15],0.995736858337803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,10,0.98 [0.65-1.47],0.905573894369118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.23 [0.68-2.22],0.500741850345725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,74,1.02 [0.98-1.07],0.317718321715999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP12,Macrophage metalloelastase,Inverse variance weighted,21,0.92 [0.85-0.98],0.014897346898462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RTBDN,Retbindin,Inverse variance weighted,5,0.83 [0.57-1.21],0.328580502321443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DRAXIN,Draxin,Inverse variance weighted,38,0.97 [0.88-1.07],0.572466805668827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,13,0.94 [0.78-1.13],0.517617772416956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK6,Kallikrein-6,Inverse variance weighted,6,1.15 [0.92-1.43],0.21823520857491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD160,CD160 antigen,Inverse variance weighted,36,1.01 [0.91-1.12],0.882993268744256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LMOD1,Leiomodin-1,Inverse variance weighted,6,0.93 [0.69-1.25],0.610950473984953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,24,0.88 [0.76-1.02],0.0999723562031248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.28 [0.58-2.81],0.538841503970539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,4,0.92 [0.74-1.15],0.470739544035163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD55,Complement decay-accelerating factor,Inverse variance weighted,27,1.05 [0.94-1.18],0.387286846792785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.09 [0.89-1.33],0.392261559539402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,10,1.08 [0.90-1.29],0.432174675649404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NTRK2,BDNF/NT-3 growth factors receptor,Inverse variance weighted,7,0.98 [0.69-1.38],0.891368973183109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,12,0.91 [0.78-1.07],0.257090460040707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,0.99 [0.88-1.11],0.828613843819682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ALCAM,CD166 antigen,Inverse variance weighted,11,0.89 [0.67-1.20],0.459174330009575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,42,0.97 [0.89-1.06],0.502056106889213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,6,0.84 [0.44-1.59],0.58722907947355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,5,0.89 [0.60-1.33],0.576039204646575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,11,1.03 [0.69-1.54],0.871500962883231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MDK,Midkine,Inverse variance weighted,19,1.17 [0.95-1.46],0.146701402628929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,25,0.97 [0.85-1.11],0.67860249495029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OGN,Mimecan,Inverse variance weighted,37,0.96 [0.86-1.07],0.439539476428415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.04 [0.90-1.22],0.576438739592176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,18,0.80 [0.62-1.02],0.0713128378362317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLXDC2,Plexin domain-containing protein 2,Inverse variance weighted,14,1.03 [0.86-1.25],0.719171391298612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,1.01 [0.87-1.16],0.92048234955683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,9,1.21 [0.96-1.52],0.100223993808553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL25,C-C motif chemokine 25,Inverse variance weighted,49,0.94 [0.88-1.01],0.0804896503029346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,17,0.89 [0.75-1.06],0.205757895678497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,15,0.89 [0.71-1.13],0.350928340449668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SFRP4,Secreted frizzled-related protein 4,Inverse variance weighted,12,1.00 [0.82-1.22],0.97678766367155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,13,1.00 [0.94-1.06],0.898365336746347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,8,0.96 [0.83-1.11],0.608142677189693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,16,1.06 [0.91-1.23],0.428983166233576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ULBP2,UL16-binding protein 2,Inverse variance weighted,37,0.96 [0.89-1.03],0.234682425202111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,15,0.95 [0.88-1.03],0.206669995689423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,6,1.34 [0.95-1.89],0.0945829487356914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFNA1,Ephrin-A1,Inverse variance weighted,15,1.14 [1.00-1.30],0.0418352549793306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,24,0.86 [0.72-1.02],0.0841893457962059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANG,Angiogenin,Inverse variance weighted,26,0.94 [0.85-1.04],0.212426447324276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.92 [0.78-1.09],0.318462426622962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FOLR2,Folate receptor beta,Inverse variance weighted,16,0.99 [0.74-1.31],0.91817403351846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,9,1.30 [1.06-1.59],0.0109231250363024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,18,1.03 [0.90-1.18],0.694681497700951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,2,0.93 [0.63-1.36],0.697191661213841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,3,0.96 [0.60-1.54],0.864052920877133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.00 [0.85-1.17],0.984644230580267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.99 [0.74-1.32],0.941927774478248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,41,1.06 [0.96-1.16],0.244942393300259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,19,0.90 [0.80-1.01],0.0711981714557045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PEAR1,Platelet endothelial aggregation receptor 1,Inverse variance weighted,14,1.02 [0.87-1.21],0.796921678395403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD27,CD27 antigen,Inverse variance weighted,18,1.10 [0.97-1.25],0.154904975935807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,16,1.12 [0.90-1.39],0.304590164681659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,0.98 [0.73-1.30],0.871643310147921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF5,Fibroblast growth factor 5,Inverse variance weighted,43,1.06 [0.98-1.14],0.143779122226855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.23 [0.78-1.93],0.377504575738333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSTB,Cystatin-B,Inverse variance weighted,25,1.03 [0.91-1.17],0.642181748985774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NECTIN4,Nectin-4,Inverse variance weighted,12,1.01 [0.83-1.22],0.944832040129928
